Cagrilintide

2D structure

Product name

Cagrilintide

Synonyms

AM833

Molecular formula

C194H312N54O59S2

Molecular weight

4409 g/mol

CAS number

1415456-99-3

PubChem CID

171397054

Purity

>= 99% (HPLC)

Form

Lyophilised powder

Appearance

White to off-white solid

Solubility

Bacteriostatic water

Storage

Lyophilised: store at -20C, dry and light-protected. Reconstituted: 2-8C.

No third-party batch reports have been uploaded for this product yet. Reports are issued by independent labs after each manufacturing batch.

What is cagrilintide?

Cagrilintide (development code AM833) is a long-acting synthetic analog of the peptide hormone amylin. It has the molecular formula C194H312N54O59S2, a molecular weight of 4409 g/mol and CAS number 1415456-99-3. Kovalabs supplies it as a lyophilised powder for laboratory research use only. It is not a medicine and is not intended for human or veterinary use.

Is cagrilintide a peptide?

Yes. Cagrilintide is a synthetic peptide, specifically a long-acting analog of human amylin. It is a single defined molecule with the formula C194H312N54O59S2 and a molecular weight of 4409 g/mol. It is supplied as a lyophilised solid as a reference compound for non-clinical laboratory research, not as a therapeutic product.

Is cagrilintide legal in the UK?

Cagrilintide is not a controlled drug under the Misuse of Drugs Act 1971 and can be supplied lawfully in the UK as a research chemical. It has no MHRA marketing authorisation, so it is not a licensed medicine and may not be sold or used for human or veterinary consumption. Kovalabs supplies it for laboratory research only, and the purchaser is responsible for lawful handling.

Is cagrilintide for human use?

No. Cagrilintide is supplied by Kovalabs for in-vitro and laboratory research use only. It is not a licensed medicine, it has no marketing authorisation, and it is not intended or supplied for human or veterinary use, ingestion or administration. Nothing on this page should be read as describing or recommending any human application.

Has cagrilintide been shown to be safe or effective in humans?

No such claim is made here. The published literature on cagrilintide consists of pre-clinical, in-vitro and animal-model work investigating amylin and calcitonin-receptor signalling. None of this establishes a benefit, effect, safety profile or outcome in humans, and cagrilintide is not a licensed medicine. It is supplied solely as a reference compound for non-clinical research.

What does the research on cagrilintide investigate?

The literature investigates cagrilintide as a tool compound in amylin and calcitonin-receptor signalling and in metabolic-pathway model systems, using pre-clinical and laboratory models. These are research-context observations only and do not establish any human benefit, effect or outcome. A referenced, study-design-only overview is available in our cagrilintide and amylin research monograph linked from this page.

What is the molecular formula and CAS number of cagrilintide?

Cagrilintide has the molecular formula C194H312N54O59S2, a molecular weight of 4409 g/mol and CAS number 1415456-99-3. Its PubChem CID is 171397054 and it is also known by the development code AM833. These identifiers are stated on each Certificate of Analysis so the supplied material can be confirmed against the expected structure.

Is all cagrilintide the same?

No. Material sold under the same name can differ in purity and identity between suppliers and batches. The only reliable way to confirm what a vial contains is a current Certificate of Analysis. Kovalabs releases each batch after independent testing, with purity assessed by HPLC at >= 99% and identity confirmed against the expected mass. Batch certificates are available on our CoA page.

What is the difference between cagrilintide and retatrutide?

They are distinct molecules. Cagrilintide is a long-acting amylin analog (formula C194H312N54O59S2). Retatrutide is a separate multi-receptor peptide with its own structure and identifiers. Both are catalogued as metabolic-research reference compounds, but they are different chemical entities. This comparison concerns molecular identity only and implies no effect or outcome in humans.

How is cagrilintide supplied and reconstituted?

Cagrilintide is supplied as a lyophilised (freeze-dried) white to off-white powder. For non-clinical laboratory work it is typically reconstituted with a compatible solvent such as bacteriostatic water before use in assays. This describes laboratory handling only; the material is not for human or veterinary administration and is provided for research use only.

How should cagrilintide be stored?

Store the lyophilised powder at -20C, kept dry and protected from light, to maintain stability. Once reconstituted, hold the solution at 2-8C and use within the working window appropriate to your protocol. Correct cold storage helps preserve peptide integrity for laboratory research. The product is for laboratory research use only, not for human or veterinary use.

Where can I buy cagrilintide in the UK?

Kovalabs supplies cagrilintide in the UK as a research-grade lyophilised peptide with a Certificate of Analysis per batch, HPLC purity of >= 99% and UK despatch. It is sold strictly for laboratory research use only and is not for human or veterinary use. Verified identifiers and batch certificates are provided so the supplied material can be confirmed before use.

Does cagrilintide have a Certificate of Analysis?

Yes. Every batch is released only after independent identity and purity testing, and a Certificate of Analysis is provided. The CoA states the verified identifiers (CAS 1415456-99-3, formula C194H312N54O59S2, molecular weight 4409 g/mol, PubChem CID 171397054) along with the HPLC purity result. Batch certificates are available on our CoA page.